Weighing the Complexity of Pathologic Response in Lung Cance

Pathologic response has emerged as a valuable endpoint and surrogate marker for overall survival in lung cancer studies, but much work remains to be done.

Related Keywords

New York , United States , Memorial Sloan Kettering Cancer Center , Williamd Travis , , Lung Cancer Conference , Clinical Oncology , International Association , Lung Cancer Recommendations , Pathologic Assessment , Lung Cancer Resection Specimens After Neoadjuvant , Lung Cancer , Ung Carcinoma , Ancer Lung , Chemotherapy , Neoadjuvant , Non Small Cell Lung Cancer , Nsclc , Neoplasm , Physician Assistants , Tumor , Breast Cancer , Alignant Breast Neoplasm , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Residual Disease , Thoracic Region Of Chest , Chest ,